Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 2
2004 6
2005 4
2006 4
2007 6
2008 1
2009 3
2010 12
2011 18
2012 9
2013 14
2014 16
2015 21
2016 14
2017 14
2018 19
2019 32
2020 14
Text availability
Article attribute
Article type
Publication date

Search Results

189 results
Results by year
Filters applied: . Clear all
Page 1
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
de Man FM, Goey AKL, van Schaik RHN, Mathijssen RHJ, Bins S. de Man FM, et al. Among authors: mathijssen rhj. Clin Pharmacokinet. 2018 Oct;57(10):1229-1254. doi: 10.1007/s40262-018-0644-7. Clin Pharmacokinet. 2018. PMID: 29520731 Free PMC article. Review.
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Henricks LM, Lunenburg CATC, de Man FM, Meulendijks D, Frederix GWJ, Kienhuis E, Creemers GJ, Baars A, Dezentjé VO, Imholz ALT, Jeurissen FJF, Portielje JEA, Jansen RLH, Hamberg P, Ten Tije AJ, Droogendijk HJ, Koopman M, Nieboer P, van de Poel MHW, Mandigers CMPW, Rosing H, Beijnen JH, Werkhoven EV, van Kuilenburg ABP, van Schaik RHN, Mathijssen RHJ, Swen JJ, Gelderblom H, Cats A, Guchelaar HJ, Schellens JHM. Henricks LM, et al. Among authors: mathijssen rhj. Lancet Oncol. 2018 Nov;19(11):1459-1467. doi: 10.1016/S1470-2045(18)30686-7. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348537 Clinical Trial.
Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective.
van Leeuwen RW, van Gelder T, Mathijssen RH, Jansman FG. van Leeuwen RW, et al. Among authors: mathijssen rh. Lancet Oncol. 2014 Jul;15(8):e315-26. doi: 10.1016/S1470-2045(13)70579-5. Lancet Oncol. 2014. PMID: 24988935 Review.
Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen.
Hussaarts KGAM, Hurkmans DP, Oomen-de Hoop E, van Harten LJ, Berghuis S, van Alphen RJ, Spierings LEA, van Rossum-Schornagel QC, Vastbinder MB, van Schaik RHN, van Gelder T, Jager A, van Leeuwen RWF, Mathijssen RHJ. Hussaarts KGAM, et al. Among authors: mathijssen rhj. Cancers (Basel). 2019 Mar 22;11(3):403. doi: 10.3390/cancers11030403. Cancers (Basel). 2019. PMID: 30909366 Free PMC article.
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.
Oza AM, Cibula D, Benzaquen AO, Poole C, Mathijssen RH, Sonke GS, Colombo N, Špaček J, Vuylsteke P, Hirte H, Mahner S, Plante M, Schmalfeldt B, Mackay H, Rowbottom J, Lowe ES, Dougherty B, Barrett JC, Friedlander M. Oza AM, et al. Among authors: mathijssen rh. Lancet Oncol. 2015 Jan;16(1):87-97. doi: 10.1016/S1470-2045(14)71135-0. Epub 2014 Dec 4. Lancet Oncol. 2015. PMID: 25481791 Clinical Trial.
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients.
Hurkmans DP, Basak EA, van Dijk T, Mercieca D, Schreurs MWJ, Wijkhuijs AJM, Bins S, Hoop EO, Debets R, Joerger M, Odink A, van der Veldt AAM, van der Leest CH, Aerts JGJV, Mathijssen RHJ, Koolen SLW. Hurkmans DP, et al. Among authors: mathijssen rhj. J Immunother Cancer. 2019 Jul 19;7(1):192. doi: 10.1186/s40425-019-0669-y. J Immunother Cancer. 2019. PMID: 31324223 Free PMC article. Clinical Trial.
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab.
Kunert A, Basak EA, Hurkmans DP, Balcioglu HE, Klaver Y, van Brakel M, Oostvogels AAM, Lamers CHJ, Bins S, Koolen SLW, van der Veldt AAM, Sleijfer S, Mathijssen RHJ, Aerts JGJV, Debets R. Kunert A, et al. Among authors: mathijssen rhj. J Immunother Cancer. 2019 Jun 8;7(1):149. doi: 10.1186/s40425-019-0608-y. J Immunother Cancer. 2019. PMID: 31176366 Free PMC article.
p16 status and choice of chemotherapy in the KEYNOTE-040 study.
Bins S, Mathijssen RHJ. Bins S, et al. Among authors: mathijssen rhj. Lancet. 2019 Oct 12;394(10206):1322-1323. doi: 10.1016/S0140-6736(19)31260-7. Lancet. 2019. PMID: 31609222 No abstract available.
Clinically relevant drug interactions with multikinase inhibitors: a review.
Hussaarts KGAM, Veerman GDM, Jansman FGA, van Gelder T, Mathijssen RHJ, van Leeuwen RWF. Hussaarts KGAM, et al. Among authors: mathijssen rhj. Ther Adv Med Oncol. 2019 Jan 4;11:1758835918818347. doi: 10.1177/1758835918818347. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 30643582 Free PMC article. Review.
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
Hurkmans DP, Verhoeven JGHP, de Leur K, Boer K, Joosse A, Baan CC, von der Thüsen JH, van Schaik RHN, Mathijssen RHJ, van der Veldt AAM, Hesselink DA. Hurkmans DP, et al. Among authors: mathijssen rhj. J Immunother Cancer. 2019 Jul 12;7(1):182. doi: 10.1186/s40425-019-0653-6. J Immunother Cancer. 2019. PMID: 31300068 Free PMC article.
189 results
Jump to page
Feedback